TD Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.71M | Buy |
|
|||||
|
2025
Q1 | $2.59M | Buy |
|
|||||
|
2024
Q4 | $1.42M | Buy |
|
|||||
|
2024
Q3 | $1.27M | Buy |
|
|||||
|
2024
Q2 | $1.16M | Sell |
|
|||||
|
2024
Q1 | $2.1M | Sell |
|
|||||
|
2023
Q4 | $6.18M | Sell |
|
|||||
|
2023
Q3 | $7.88M | Buy |
|
|||||
|
2023
Q2 | $5.98M | Sell |
|
|||||
|
2023
Q1 | $7.29M | Buy |
|
|||||
|
2022
Q4 | $7.96M | Buy |
|
|||||
|
2022
Q3 | $7.72M | Sell |
|
|||||
|
2022
Q2 | $8.65M | Buy |
|
|||||
|
2022
Q1 | $6.55M | Buy |
|
|||||
|
2021
Q4 | $6.67M | Buy |
|
|||||
|
2021
Q3 | $5.58M | Sell |
|
|||||
|
2021
Q2 | $5.94M | Buy |
|
|||||
|
2021
Q1 | $6.67M | Buy |
|
|||||
|
2020
Q4 | $7.37M | Sell |
|
|||||
|
2020
Q3 | $10.9M | Buy |
|
|||||
|
2020
Q2 | $9.17M | Buy |
|